• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102204-005
Device Problem Imprecision (1307)
Patient Problem Hypoglycemia (1912)
Event Date 03/16/2019
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of an internal review.The investigation of the data available in the data management system showed that the eversense sensor glucose value was recorded at 237 mg/dl at 11:00pm the day of the event.At 12:00 am the eversense sensor glucose value was at 203 mg/dl.The user reported taking insulin at 11:00pm and tested his blood glucose via a fingerstick and reported the value was 20 mg/dl around 12 am.The user did not enter the blood glucose value as a manual entry nor as a calibration in the system.The eversense sensor value never went below 113mg/dl until around 4 am and as a result the low glucose alert was not triggered.The cgm also has the lowest glucose operational limit of 40 mg/dl.A potential cause of the discrepancy with the reported blood glucose value is likely due to transient sensor inaccuracy caused by sensor lag, at that range of time (12:05am-12:30am), when the glucose was dropping fast at > 2mg/dl/min.However, this could not be confirmed based on the available recorded data.The blood glucose entries entered by the user during the week prior to the reported incident, matched closely with the cgm value.
 
Event Description
On march 22, 2023, senseonics was made aware of an instance wherein a patient using eversense cgm system went through a hypoglycemia event.The patient reported the eversense cgm system reported a high glucose reading which resulted in him treating himself with insulin, which lowered high actual blood glucose resulting in the hypoglycemia event.The patient also reported that he verified his glucose levels using a blood glucose meter prior to treating himself with insulin.The patient was subsequently taken to the hospital to receive care from a physician.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18415800
MDR Text Key331577523
Report Number3009862700-2023-00361
Device Sequence Number1
Product Code QCD
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/22/2019
Device Model Number102204-005
Device Lot Number109181
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/16/2019
Initial Date FDA Received12/28/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/22/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-